Profusa Awarded $1.75M NIH Grant To Further Develop Tissue-Integrated Biosensors For Continuous Oxygen Monitoring In PAD Patients

Profusa, Inc., a leading developer of tissue-integrated biosensors, today announced that the National Institutes of Health has awarded it a $1.75 million grant under the Small Business Innovation Research (SBIR) program. Adminis­tered by the National Heart, Lung, and Blood Institute (NHLBI), the funding will support Fast-tracked Phase I and Phase II studies of the company's Lumee™ tissue-integrated biosensors for continuous monitoring of oxygen toward improving the clinical outcomes of patients suffering from peripheral artery disease (PAD).
Source: Medical Design Online News - Category: Medical Equipment Source Type: news